Scholars Central

Conference abstractPublished 18 Jul 2018

Immunological properties of NSC-631570 (Ukraine) - The anti-cancer preparation on basis of greater Celandine alkaloids

Authors: Wassil Nowicky

Ukrainian Anti-Cancer Institute, Austria

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The preparation NSC-631570 (UKRAIN) is the very first preparation against cancer with a selective effect, which means that in therapeutic dosage it kills only cancer cells leaving the healthy cells undamaged. For the invention of this preparation, the factor used was that can-cer cells are more negatively charged than normal cells. For this purpose the Celandine alka-loid with a positive charge has been used, due to which it accumulates in cancer cells very fast that is visible under the UV-light due to the auto fluorescence. The anti-cancer preparation NSC-631570 has the ability to capsule cancer tumors, thanks to which the creation of new metastases is stopped. Besides, this ability makes the surgical removal of the tumors much more easier. These abilities of the NSC-631570 have been confirmed by the 188 research works at 60 universities and research centers from 24 countries. To the NSC-631570 more than 300 scientific publications are dedicated and over 180 of them can be found on PubMed. The NSC-631570 possesses some distinct immune properties. In several immune target-effector systems NSC- 631570 significantly amplified the malignotoxic activity of macrophages, lymphocytes and NK cells, and stimulates dendritic cells maturation in vitro. While the parameters like B-lymphocytes count, immune globulin concentrations, complement and acute phase proteins did not changed significantly, it can be postulated NSC-631570 modulates the cellular part of the immune system whereas the humoral part remains unaffected.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Wassil Nowicky”